-
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
Rodriguez-Mogeda, C., van Lierop, Z. Y. G. J., van der Pol, S. M. A., Coenen, L., Hogenboom, L., Kamermans, A., Rodriguez, E., van Horssen, J., van Kempen, Z. L. E., Uitdehaag, B. M. J., Teunissen, C. E., Witte, M. E., Killestein, J. & de Vries, H. E., Dec 2023, In: Journal of neuroinflammation. 20, 1, p. 215 215.Research output: Contribution to journal › Article › Academic › peer-review
-
Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2
Vacondio, D., Nogueira Pinto, H., Coenen, L., Mulder, I. A., Fontijn, R., van het Hof, B., Fung, W. K., Jongejan, A., Kooij, G., Zelcer, N., Rozemuller, A. J., de Vries, H. E. & de Wit, N. M., 1 Nov 2023, In: Cell Death & Disease. 14, 11, p. 781 781.Research output: Contribution to journal › Article › Academic › peer-review
-
Markers of aging: Unsupervised integrated analyses of the human plasma proteome
Coenen, L., Lehallier, B., de Vries, H. & Middeldorp, J., 2023, In: Frontiers in aging. 4, p. 1112109 1112109.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
